Poseida Therapeutics, Inc. Long-Term Debt
Poseida Therapeutics, Inc. had Long-Term Debt of $58.91 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2024-11-07
- 2024-09-30: Long-term Debt, Excluding Current Maturities $58.91M.
- 2024-06-30: Long-term Debt, Excluding Current Maturities $58.80M.
- 2024-03-31: Long-term Debt, Excluding Current Maturities $58.69M.
- 2023-12-31: Long-term Debt, Excluding Current Maturities $58.59M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2024-09-30 | $58.91M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $58.80M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $58.69M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $58.59M 10-Q · filed 2024-11-07 |
| 2023-09-30 | $58.49M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $58.40M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $58.32M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $58.25M 10-K · filed 2024-03-07 |
| 2022-09-30 | $58.16M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $58.06M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $57.97M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $29.36M 10-K · filed 2023-03-09 |
| 2021-09-30 | $29.31M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $29.27M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $26.21M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $29.13M 10-K · filed 2022-03-10 |
| 2020-09-30 | $29.06M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $28.99M 10-Q · filed 2020-08-20 |
| 2019-12-31 | $26.14M 10-K · filed 2021-03-11 |